FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387309008: Tetracaine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461487018 Tetracaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481410015 Tetracaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491986014 Amethocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4499171000005113 Tetracain da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetracaine (substance) Is a lokalanæstetikum af estertype false Inferred relationship Some
Tetracaine (substance) Is a Drug allergen false Inferred relationship Some
Tetracaine (substance) Is a Ester false Inferred relationship Some
Tetracaine (substance) Is a Local anesthetic (substance) false Inferred relationship Some
Tetracaine (substance) Is a Benzoic acid ester and/or benzoic acid ester derivative (substance) false Inferred relationship Some
Tetracaine (substance) Is a Benzoic acid ester local anesthetic true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental tetracaine poisoning Causative agent False Tetracaine (substance) Inferred relationship Some
Intentional tetracaine poisoning Causative agent False Tetracaine (substance) Inferred relationship Some
forgiftning med tetracain, uvist med hvilken hensigt Causative agent False Tetracaine (substance) Inferred relationship Some 1
Allergy to tetracaine Causative agent False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 2 % øjendråber The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 1 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 0,5 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracain 4 % gel + forbinding The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracain 4 % gel + okkluderende forbinding The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Tetracaine hydrochloride 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracain til topisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 0,2 %/glucose 6% injektionsvæske, opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 0,3 %/glucose 6 % injektionsvæske, opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Tetracaine hydrochloride 20 mg/g cutaneous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Tetracaine hydrochloride 5 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 10 mg/ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 5 mg/ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
tetracainhydrochlorid 3 mg/ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Product containing tetracaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Poisoning by tetracaine Causative agent True Tetracaine (substance) Inferred relationship Some 1
Tetracaine measurement Component True Tetracaine (substance) Inferred relationship Some 1
Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Eludril oral spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
benzocain + butamben + tetracainhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Tetracaine hydrochloride Is a False Tetracaine (substance) Inferred relationship Some
Amethocaine adverse reaction Causative agent False Tetracaine (substance) Inferred relationship Some
Intentional tetracaine poisoning Causative agent True Tetracaine (substance) Inferred relationship Some 1
Adverse reaction to tetracaine Causative agent True Tetracaine (substance) Inferred relationship Some 1
Product containing lidocaine and tetracaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
lidocain 70 mg + tetracain 70 mg depotplaster The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Product containing chlorhexidine and tetracaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 2
tetracain til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some
Product containing tetracaine in oropharyngeal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some 1
Tetracaine-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Accidental poisoning by tetracaine Causative agent True Tetracaine (substance) Inferred relationship Some 1
Allergy to tetracaine Causative agent True Tetracaine (substance) Inferred relationship Some 1
Tetracaine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tetracaine (substance) Inferred relationship Some
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tetracaine (substance) Inferred relationship Some 1
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tetracaine (substance) Inferred relationship Some 1
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tetracaine (substance) Inferred relationship Some 2
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Tetracaine (substance) Inferred relationship Some 2
Product containing tetracaine in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Product containing tetracaine in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Product containing lidocaine and tetracaine in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Chlorhexidine and tetracaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 2
Product containing only tetracaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Lidocaine and tetracaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Product containing only lidocaine and tetracaine in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Tetracaine only product in ocular dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Tetracaine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Tetracaine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Tetracaine only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tetracaine (substance) Inferred relationship Some 1
Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tetracaine (substance) Inferred relationship Some 1
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tetracaine (substance) Inferred relationship Some 2
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Tetracaine (substance) Inferred relationship Some 2
Product containing only chlorhexidine and tetracaine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some 2
Product containing chlorhexidine and tetracaine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tetracaine (substance) Inferred relationship Some 2
Product containing tetracaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 1
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tetracaine (substance) Inferred relationship Some 1
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tetracaine (substance) Inferred relationship Some 1
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tetracaine (substance) Inferred relationship Some 2
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tetracaine (substance) Inferred relationship Some 2
Chlorhexidine- and tetracaine-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 2
Product containing only chlorhexidine and tetracaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tetracaine (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start